Shinpoong Pharmaceutical Co.,Ltd (KRX: 019170)
South Korea
· Delayed Price · Currency is KRW 10,880
+180 (1.68%)
Nov 18, 2024, 3:30 PM KST
Shinpoong Pharmaceutical Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 208,776 | 200,229 | 209,288 | 189,237 | 197,751 | 189,722 | Upgrade
|
| Other Revenue | - | - | -0 | - | - | -0 | Upgrade
|
| Revenue | 208,776 | 200,229 | 209,288 | 189,237 | 197,751 | 189,722 | Upgrade
|
| Revenue Growth (YoY) | -2.28% | -4.33% | 10.60% | -4.31% | 4.23% | 1.24% | Upgrade
|
| Cost of Revenue | 129,345 | 119,951 | 131,315 | 111,850 | 121,224 | 113,537 | Upgrade
|
| Gross Profit | 79,430 | 80,277 | 77,973 | 77,388 | 76,527 | 76,185 | Upgrade
|
| Selling, General & Admin | 76,166 | 79,068 | 76,549 | 69,256 | 59,480 | 58,011 | Upgrade
|
| Research & Development | 32,170 | 42,277 | 30,383 | 17,334 | 5,622 | 5,967 | Upgrade
|
| Other Operating Expenses | 365.11 | 394.37 | 646.98 | 3,241 | 778.8 | 343.67 | Upgrade
|
| Operating Expenses | 110,255 | 127,670 | 111,992 | 91,694 | 68,782 | 70,583 | Upgrade
|
| Operating Income | -30,825 | -47,392 | -34,019 | -14,306 | 7,746 | 5,602 | Upgrade
|
| Interest Expense | -2,453 | -1,719 | -61.42 | -202.06 | -2,945 | -4,115 | Upgrade
|
| Interest & Investment Income | 983.78 | 1,174 | 1,026 | 1,878 | 1,946 | 1,515 | Upgrade
|
| Earnings From Equity Investments | -6,741 | -6,514 | -697.09 | 2,620 | 2,520 | 691.61 | Upgrade
|
| Currency Exchange Gain (Loss) | 509.32 | 1,328 | -1,009 | 406.81 | -1,128 | 478.42 | Upgrade
|
| Other Non Operating Income (Expenses) | 495.03 | 653.36 | -182.48 | 314.91 | -415.97 | -680.89 | Upgrade
|
| EBT Excluding Unusual Items | -38,031 | -52,471 | -34,942 | -9,288 | 7,724 | 3,492 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,386 | -1,011 | 845.62 | 253.64 | -868.38 | 72.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | 7.69 | 39.65 | 18.31 | 49.02 | -29.96 | -386.17 | Upgrade
|
| Asset Writedown | - | - | -703.23 | - | - | - | Upgrade
|
| Pretax Income | -39,410 | -53,442 | -34,782 | -8,986 | 8,340 | 7,119 | Upgrade
|
| Income Tax Expense | 4,459 | 3,831 | 527.29 | 2,540 | 3,294 | 1,724 | Upgrade
|
| Earnings From Continuing Operations | -43,869 | -57,273 | -35,309 | -11,526 | 5,046 | 5,395 | Upgrade
|
| Minority Interest in Earnings | -73.73 | -52.86 | -68.14 | -57.61 | -42.93 | -71.16 | Upgrade
|
| Net Income | -43,943 | -57,325 | -35,377 | -11,584 | 5,003 | 5,324 | Upgrade
|
| Preferred Dividends & Other Adjustments | -2,311 | -2,198 | - | - | - | 243.65 | Upgrade
|
| Net Income to Common | -41,632 | -55,127 | -35,377 | -11,584 | 5,003 | 5,080 | Upgrade
|
| Net Income Growth | - | - | - | - | -6.03% | 89.88% | Upgrade
|
| Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 50 | 50 | Upgrade
|
| Shares Outstanding (Diluted) | 51 | 51 | 51 | 51 | 50 | 50 | Upgrade
|
| Shares Change (YoY) | -2.37% | - | - | 1.86% | 0.71% | 4.15% | Upgrade
|
| EPS (Basic) | -812.13 | -1075.40 | -690.12 | -225.97 | 99.40 | 101.66 | Upgrade
|
| EPS (Diluted) | -812.13 | -1075.40 | -690.12 | -225.97 | 99.40 | 101.66 | Upgrade
|
| EPS Growth | - | - | - | - | -2.22% | 83.17% | Upgrade
|
| Free Cash Flow | -33,357 | -39,736 | -31,767 | -75,453 | 17,408 | 7,276 | Upgrade
|
| Free Cash Flow Per Share | -650.70 | -775.15 | -619.69 | -1471.90 | 345.89 | 145.61 | Upgrade
|
| Dividend Per Share | - | - | - | - | 100.000 | - | Upgrade
|
| Gross Margin | 38.05% | 40.09% | 37.26% | 40.89% | 38.70% | 40.16% | Upgrade
|
| Operating Margin | -14.76% | -23.67% | -16.25% | -7.56% | 3.92% | 2.95% | Upgrade
|
| Profit Margin | -19.94% | -27.53% | -16.90% | -6.12% | 2.53% | 2.68% | Upgrade
|
| Free Cash Flow Margin | -15.98% | -19.85% | -15.18% | -39.87% | 8.80% | 3.84% | Upgrade
|
| EBITDA | -18,750 | -35,484 | -21,215 | -1,631 | 19,954 | 17,917 | Upgrade
|
| EBITDA Margin | -8.98% | -17.72% | -10.14% | -0.86% | 10.09% | 9.44% | Upgrade
|
| D&A For EBITDA | 12,075 | 11,908 | 12,803 | 12,675 | 12,208 | 12,314 | Upgrade
|
| EBIT | -30,825 | -47,392 | -34,019 | -14,306 | 7,746 | 5,602 | Upgrade
|
| EBIT Margin | -14.76% | -23.67% | -16.25% | -7.56% | 3.92% | 2.95% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 39.50% | 24.21% | Upgrade
|
| Advertising Expenses | - | 17,979 | 19,126 | 17,097 | 15,574 | 9,860 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.